Personal information

Activities

Employment (8)

Complutense University of Madrid: Madrid, ES

2022-04-01 to present | Postdoctoral Researcher (Bioquimica y Biologia Molecular)
Employment
Source: Self-asserted source
Marco Cordani

Health Research Institute of the Hospital Clínico San Carlos: Madrid, ES

2022-02-01 to 2022-03-31 | Postdoctoral Researcher
Employment
Source: Self-asserted source
Marco Cordani

Centre de Recherche en Cancérologie de Lyon: Lyon, Rhône-Alpes, FR

2021-01-19 to 2022-01-18 | Postdoctoral Researcher ( Tumor Escape, Resistance and Immunity)
Employment
Source: Self-asserted source
Marco Cordani

IMDEA Nanoscience: Madrid, ES

2018-04 to 2020-12-31 | Research Staff (Nanomedicine - Bionanotechnology lab)
Employment
Source: Self-asserted source
Marco Cordani

Universidad Autónoma de Madrid Facultad de Medicina: Madrid, Madrid, ES

2017-03-01 to 2018-02 | Post-doctoral fellow (Departamento de Bioquimica)
Employment
Source: Self-asserted source
Marco Cordani

Università degli Studi di Verona: Verona, Veneto, IT

2013-10-01 to 2016-12-31 | PhD student (Sezione di Biochimica)
Employment
Source: Self-asserted source
Marco Cordani

Centro Nacional de Investigaciones Cardiovasculares: Madrid, ES

2013-06-01 to 2013-09-01 | Fellow post graduate
Employment
Source: Self-asserted source
Marco Cordani

Centro Nacional de Investigaciones Oncológicas: Madrid, Madrid, ES

2011-07-01 to 2011-08-31
Employment
Source: Self-asserted source
Marco Cordani

Education and qualifications (3)

Università degli Studi di Verona: Verona, Veneto, IT

2014-01-01 to 2017-05-24 | PhD student (Sezione di Biochimica)
Education
Source: Self-asserted source
Marco Cordani

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2010-10-01 to 2013-02-26 | Master Degree in Molecular Biology
Education
Source: Self-asserted source
Marco Cordani

Università degli Studi di Parma: Parma, Emilia-Romagna, IT

2007-09-01 to 2010-07-10 | Bachelor Degree in Biotechnology
Education
Source: Self-asserted source
Marco Cordani

Professional activities (5)

SEFAGIA - Autophagy Spanish Society: Madrid, ES

2022-11 to present | Ordinary member
Membership
Source: Self-asserted source
Marco Cordani

European Association For Cancer Research: Nottingham, Nottingham, GB

2019-04 to present | Young member
Membership
Source: Self-asserted source
Marco Cordani

European Society of Nanomedicine: Basel, CH

2019 to present
Membership
Source: Self-asserted source
Marco Cordani

British Society for Nanomedicine: Liverpool, GB

2019 to present
Membership
Source: Self-asserted source
Marco Cordani

Italian association of cell culture: L'Aquila, IT

2014 to 2016 | Young
Membership
Source: Self-asserted source
Marco Cordani

Funding (7)

DEVELOPMENT OF CANCER THERAPIES BASED ON THE INHIBITION OF ONCOGENIC SIGNALLING PATHWAYS AND TREATMENT WITH CANNABINOIDS

2023-01 to 2027-12 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

RYC2021-031003-I

Source: Self-asserted source
Marco Cordani

ADVANCED STRATEGIES AND NEW APPROACHES FOR PROTONTHERAPY

2023-01 to 2026-12 | Grant
Comunidad de Madrid (Madrid, ES)
Part of GRANT_NUMBER:

S2022/BMD-7434 ASAP-CM

Source: Self-asserted source
Marco Cordani

NOVEL INDIVIDUALIZED THERAPIES AGAINST GLIOMAS BASED ON BLOCKING THE MDK /ALK PATHWAY AND TREATMENT WITH CANNABINOIDS

2022-04 to 2024-03 | Contract
Ministerio de Universidades (Madrid, ES)
Source: Self-asserted source
Marco Cordani

Investigation, preparation and characterization (physical, chemical and of stability) of biomolecules and nanoparticles of biomedical interest.

2018-05 to 2018-12 | Contract
Consejería de Educación, Juventud y Deporte, Comunidad de Madrid (Madrid, Comunidad de Madrid, ES)
GRANT_NUMBER:

IND2017/IND7809

Source: Self-asserted source
Marco Cordani

MADRID NETWORK OF NANOMEDICINE IN MOLECULAR IMAGING

2018-01 to 2021-12 | Grant
Comunidad de Madrid (Madrid, ES)
Part of GRANT_NUMBER:

S2017/BMD-3867 RENIM-CM

Source: Self-asserted source
Marco Cordani

SMART NANOSTRUCTURES AGAINST UVEAL MELANOMA AND PANCREATIC CANCER

2018-01 to 2020-12 | Grant
Ministerio de Economía y Competitividad (Madrid, ES)
Part of GRANT_NUMBER:

SAF2017-87305-R

Source: Self-asserted source
Marco Cordani

From secretome knowledge to personalized therapy in pancreatic cancer patients wuth mutant p53

2016-01 to 2018-12 | Grant
Università degli Studi di Verona (Verona, IT)
GRANT_NUMBER: undefined id
Source: Self-asserted source
Marco Cordani

Peer review (228 reviews for 67 publications/grants)

Review activity for ACS applied nano materials. (4)
Review activity for Advanced therapeutics. (1)
Review activity for Ageing research reviews. (2)
Review activity for Analytical biochemistry. (1)
Review activity for Annals of translational medicine. (1)
Review activity for Antioxidants & redox signaling. (2)
Review activity for Antioxidants. (17)
Review activity for Apoptosis (1)
Review activity for Archives of biochemistry and biophysics. (1)
Review activity for Autophagy reports. (2)
Review activity for Biochemistry and biophysics reports. (1)
Review activity for Biochimica et biophysica acta. (5)
Review activity for Bioconjugate chemistry. (1)
Review activity for Bioconjugate chemistry. (1)
Review activity for Biology. (2)
Review activity for Biomedicine & pharmacotherapy. (6)
Review activity for Biomedicines. (5)
Review activity for Biomolecules. (3)
Review activity for Cancer letters. (8)
Review activity for Cancers. (12)
Review activity for Cell biology and toxicology. (1)
Review activity for Cell biology and toxicology. (1)
Review activity for Cell death and disease. (1)
Review activity for Cells. (9)
Review activity for Cellular and molecular life sciences (1)
Review activity for Cellular and molecular life sciences (1)
Review activity for Clinical and translational medicine. (4)
Review activity for Communications biology. (2)
Review activity for Emergent materials. (1)
Review activity for European journal of pharmaceutical sciences. (1)
Review activity for European journal of pharmacology. (3)
Review activity for FEBS letters. (1)
Review activity for Frontiers in bioscience. (1)
Review activity for Frontiers in cell and developmental biology. (1)
Review activity for Frontiers in molecular biosciences. (1)
Review activity for Frontiers in oncology. (2)
Review activity for Frontiers in pharmacology. (2)
Review activity for Gene reports. (1)
Review activity for International journal of environmental research and public health (5)
Review activity for International journal of molecular sciences. (23)
Review activity for International journal of nanomedicine (1)
Review activity for Journal of cancer research and clinical oncology. (2)
Review activity for Journal of personalized medicine. (3)
Review activity for Life sciences. (2)
Review activity for Materials today chemistry. (1)
Review activity for Mechanisms of ageing and development. (1)
Review activity for Metabolites. (3)
Review activity for Micromachines. (2)
Review activity for Molecular biology reports. (2)
Review activity for Molecular biology reports. (3)
Review activity for Molecular cancer (2)
Review activity for Molecules. (5)
Review activity for Nanomaterials. (7)
Review activity for Nanomedicine. (1)
Review activity for Nanoscale advances. (1)
Review activity for Nanotoxicology (1)
Review activity for Oxidative medicine and cellular longevity. (3)
Review activity for Pharmaceuticals. (4)
Review activity for Pharmaceutics. (20)
Review activity for Pharmacology & therapeutics. (1)
Review activity for PloS one. (3)
Review activity for Precision medical sciences. (1)
Review activity for Scientific reports. (1)
Review activity for Toxicology in vitro. (5)
Review activity for Toxicology in vitro. (11)
Review activity for Toxics. (3)
Review activity for Trends in cell biology. (1)